Stock Events

Stock Events

Neurobiological Technologies 

$0.000100
3
+$0.00+0% Friday 20:00

Statistics

Day High
0.000001
Day Low
0.000001
52W High
0.0001
52W Low
0.000001
Volume
1,100
Avg. Volume
0
Mkt Cap
0
P/E Ratio
0
Dividend Yield
-
Dividend
-

Dividends

0%Dividend Yield
Dec 12
$0.05
10Y Growth
N/A
5Y Growth
N/A
3Y Growth
N/A
1Y Growth
N/A

Earnings

6NovExpected
Q1 2007
Q2 2007
Q3 2007
Q4 2007
Q1 2008
Q2 2008
Q3 2008
-1.05
-0.73
-0.42
-0.1
Expected EPS
-0.16
Actual EPS
-0.1

Competitors

This list is an analysis based on recent market events. It's not an investment recommendation.
Biogen
BIIB
Mkt Cap32.28B
Biogen focuses on neurodegenerative diseases, directly competing in the neurological treatment space similar to NTII.
Lilly(Eli) &
LLY
Mkt Cap1.05T
Eli Lilly has a strong portfolio in neurology and psychiatric conditions, overlapping with NTII's focus areas.
Pfizer
PFE
Mkt Cap159.36B
Pfizer has significant investments in treatments for neurological disorders, making it a direct competitor.
Merck
MRK
Mkt Cap366B
Merck operates in the neurology sector, particularly in the development of treatments for conditions like Alzheimer's, similar to NTII's interests.
Novartis
NVS
Mkt Cap292.35B
Novartis offers several products for neurological conditions, competing in the same market as NTII.
Gilead Sciences
GILD
Mkt Cap180.64B
Gilead Sciences has expanded into the neurology space, positioning it as a competitor in the neurological treatment market.
Abbvie
ABBV
Mkt Cap451.46B
AbbVie has a growing focus on neurological diseases, including Parkinson’s and Alzheimer’s, directly competing with NTII.
AMGEN
AMGN
Mkt Cap233.78B
Amgen has research initiatives in neurodegenerative diseases, aligning it as a competitor to NTII.
Teva- Pharmaceutical Industries
TEVA
Mkt Cap42.46B
Teva Pharmaceutical specializes in generic and specialty medicines, including treatments for neurological conditions, competing with NTII.
Johnson & Johnson
JNJ
Mkt Cap645.95B
Johnson & Johnson, through its pharmaceutical division Janssen, is involved in developing treatments for neurological disorders, competing with NTII.

About

Neurobiological Technologies, Inc. (NTII) is currently undergoing a liquidation and dissolution process, a plan that received stockholder endorsement in October 2009. In its earlier operations, the company's core focus was on the development of experimental pharmaceutical treatments for various human ailments. This firm, which was established in 1987, has its primary location in Emeryville, California.
Show more...
CEO
John B. Stuppin
Employees
4
Country
United States
ISIN
US64124W3043

Listings

OTC Link
US
NTII

0 Comments

Share your thoughts

FAQ

What is Neurobiological Technologies stock price today?▼
The current price of NTII is $0.00 USD — it has increased by +0% in the past 24 hours. Watch Neurobiological Technologies stock price performance more closely on the chart.
What is Neurobiological Technologies stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on OTC Link exchange Neurobiological Technologies stocks are traded under the ticker NTII.
Is Neurobiological Technologies stock price growing?▼
NTII stock has risen by +0% compared to the previous week, the month change is a +0% rise, over the last year Neurobiological Technologies has showed a +0% increase.
What were Neurobiological Technologies earnings last quarter?▼
NTII earnings for the last quarter are -0.1 USD per share, whereas the estimation was -0.16 USD resulting in a +37.5% surprise. The estimated earnings for the next quarter are N/A USD per share.
Does Neurobiological Technologies pay dividends?▼
Yes, NTII dividends are paid en. The last dividend per share was 0.05 USD. As of today, Dividend Yield (FWD)% is 0%.
How many employees does Neurobiological Technologies have?▼
As of September 04, 2026, the company has 4 employees.
In which sector is Neurobiological Technologies located?▼
Neurobiological Technologies operates in the Health & Wellness sector.
When did Neurobiological Technologies complete a stock split?▼
The last stock split for Neurobiological Technologies was on September 17, 2007 with a ratio of 1:7.
Where is Neurobiological Technologies headquartered?▼
Neurobiological Technologies is headquartered in EmeryVille, United States.